J Jacobs Solutions edges down 077 after Q1 2026 EPS lands 1 below analyst consensus estimates Moderna Inc MRNA Counterparty Arbutus Biopharma Secures Regulatory Catalyst Amid Settled LNP Licensing Agreement KLA Corporation KLAC Rallies 64 Amid Broad Semiconductor Sector Tailwinds From Expanding AI Demand